Alico Inc (ALCO) valuation
Alico P/E ratio history
Alico trades at 178.1 times its earnings over the last twelve months. At its last 8 fiscal year ends its P/E ranged from 6.7 (year to Sep 2019) to 104.0 (year to Sep 2023), with a median of 19.3.
| Fiscal year ended | Price | EPS | P/E |
|---|---|---|---|
| Sep 30, 2025 | $34.66 | -$19.29 | n/m |
| Sep 30, 2024 | $27.97 | $0.91 | 30.7 |
| Sep 30, 2023 | $24.96 | $0.24 | 104.0 |
| Sep 30, 2022 | $28.24 | $1.66 | 17.0 |
| Sep 30, 2021 | $34.24 | $4.64 | 7.4 |
| Sep 30, 2020 | $28.62 | $3.16 | 9.1 |
| Sep 30, 2019 | $34.02 | $5.06 | 6.7 |
| Sep 30, 2018 | $33.80 | $1.56 | 21.7 |
| Sep 30, 2017 | $34.15 | -$1.14 | n/m |
| Sep 30, 2016 | $26.86 | $0.84 | 32.0 |
n/m: not meaningful (a loss, or earnings close to zero). The daily P/E line is a chart indicator in the app.
Alico valuation against its peers
| Company | Market value | P/E | Forward P/E | Price / sales |
|---|---|---|---|---|
| AlicoALCO | $277M | 178.1 | — | 16.2 |
| Usana Health SciencesUSNA | $264M | — | 11.2 | 0.3 |
| BrcBRCC | $314M | — | 51.5 | 0.7 |
| Nu Skin EnterprisesNUS | $226M | — | 4.7 | 0.2 |
| Lifeway FoodsLWAY | $350M | 33.2 | 24.8 | 1.4 |
| Natures Sunshine ProductsNATR | $215M | 12.1 | 10.6 | 0.4 |
| Mgp IngredientsMGPI | $367M | — | 9.1 | 0.8 |
| Vital FarmsVITL | $371M | — | — | 0.5 |
| LimoneiraLMNR | $194M | — | 61.4 | 1.5 |
| Peer median | 22.7 | 11.2 | 0.6 |
Reading these multiples
The P/E divides the share price by earnings per share over the last twelve months; the forward P/E divides it by the earnings analysts expect over the next twelve. Price to sales compares the company's market value with its revenue over the last twelve months. A multiple reads differently from one industry to the next, so the peer group above is the fairer comparison.
See also: ALCO financials · ALCO returns
No forecast, no recommendation. This page describes Alico Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.